HLB Life Science Co., Ltd. (KOSDAQ: 067630)

HLB Life Science Revenue

HLB Life Science had revenue of 26.08B KRW in the quarter ending September 30, 2024, with 19.41% growth. This brings the company's revenue in the last twelve months to 97.11B, down -4.72% year-over-year. In the year 2023, HLB Life Science had annual revenue of 97.99B, down -1.61%.

• Revenue (ttm): 97.11B
• Revenue Growth: -4.72%
• P/S Ratio: 10.59
• Revenue / Employee: 669.72M
• Employees: 145
• Market Cap: 1,152.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	97.99B	-1.60B	-1.61%
Dec 31, 2022	99.59B	46.10B	86.17%
Dec 31, 2021	53.49B	-38.30B	-41.73%
Dec 31, 2020	91.80B	-22.22B	-19.49%
Dec 31, 2019	114.02B	11.54B	11.26%